Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimebon in mild-to-moderate Alzheimer's disease on Donepezil
NCT00829374Phase 3Completed
- Sponsor
- Medivation
- Start
- Mar 2009
- Primary completion
- Dec 2011
- Modality
- Classical Binding Small Molecules, DNA Intercalators/Alkylators
- Countries
- 10
01
Overview
A Phase 3 trial of latrepirdine in Alzheimer's disease (AD), sponsored by Medivation. Started Mar 2009; status: completed.
02
Drugs
latrepirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00829374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829374.